Abstract:Human papillomaviruses (HPV) are small DNA viruses associated with cervical cancer, warts, and other epithelial tumors. Structural studies have shown that the HPV capsid consists of 360 copies of the major capsid protein, L1, arranged as 72 pentamers in a T=7 icosahedral lattice, coassembling with substoichiometric amounts of the minor capsid protein, L2. However, the residues involved in the coassembly of L1 and L2 remain undefined due to the lack of structure information. Here, we investigated the solvent accessibility surfaces (SASs) of the central cavity residues of the HPV16 L1 pentamer in the crystal structure because those internal exposed residues might mediate the association with L2. Twenty residues in L1 protein were selected to be analyzed, with four residues in the lumen of the L1 pentamer identified as important: F256, R315, Q317, and T340. Mutations to these four residues reduced the PsV (pseudovirus) infection capacity in 293FT cells, and mutations to R315, Q317, and T340 substantially perturb L2 from coassembling into L1 capsid. Compared with wild-type (WT) PsVs, these mutant PsVs also have a reduced ability to become internalized into host cells. Finally, we identified a stretch of negatively charged residues on L2 (amino acids [aa] 337 to 340 [EEIE]), mutations to which completely abrogate L2 assembly into L1 capsid and subsequently impair the endocytosis and infectivity of HPV16 PsVs. These findings shed light on the elusive coassembly between HPV L1 and L2. IMPORTANCE Over 200 types of HPV have been isolated, with several high-risk types correlated with the occurrence of cervical cancer. The HPV major capsid protein, L1, assembles into a T=7 icosahedral viral shell, and associates with the minor capsid protein, L2, which plays a critical role in the HPV life cycle. Despite the important role of the L2 protein, its structure and coassembly with L1 remain elusive. In this study, we analyzed the amino acid residues at the proposed interface between L1 and L2. Certain mutations at these sites decreased the amount of L2 protein assembled into the capsid, which, in turn, led to a decrease in viral infectivity. Knowledge about these residues and the coassembly of L1 and L2 could help to expand our understanding of HPV biology and aid in the development of countermeasures against a wide range of HPV types by targeting the L2 protein.

Effects of site-directed mutagenesis of L469 in helix-5 of human papillomavirus 16 L1 on pentamer formation

The critical residues of helix 5 for in vitro pentamer formation and stability of the papillomavirus capsid protein, L1.

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

A Point Mutation in the DNA-binding Domain of HPV-2 E2 Protein Increases Its DNA-binding Capacity and Reverses Its Transcriptional Regulatory Activity on the Viral Early Promoter.

Stop Codon Mutagenesis for Homogenous Expression of Human Papillomavirus L1 Protein in Escherichia Coli.

Electronic Supplementary Information : The Critical Residues of Helix 5 for in vitro Pentamer Formation and Stability of Papillomavirus Capsid Protein , L 1

Enantioselective Inhibition of Human Papillomavirus L1 Pentamer Formation by Chiral‐Proline Modified Calix[4]arenes: Targeting the Protein Interface

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles

Enhanced Expression of Soluble Human Papillomavirus L1 Through Coexpression of Molecular Chaperonin in Escherichia Coli

Peptidic Inhibitors for in Vitro Pentamer Formation of Human Papillomavirus Capsid Protein L1.

A novel C-terminal modification method enhanced the yield of human papillomavirus L1 or chimeric L1-L2 virus-like particles in the baculovirus system

Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.

Single Mutation Effects On Conformational Change And Membrane Deformation Of Influenza Hemagglutinin Fusion Peptides

The enhancement of DNA binding ability of a mutated E2 (A338V) protein of HPV-2]

A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses.

PRELIMINARY STUDY OF A NOVEL HUMAN PAPILLOMAVIRUS TYPE 16 L1/E6-E7 CHIMERIC RECOMBINANT DNA VACCINE

Impact of Naturally Occurring Variation in the Human Papillomavirus 52 Capsid Proteins on Recognition by Type-Specific Neutralising Antibodies.

High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16

Molecular dynamics simulation and purification of chimeric L1/L2 protein from human papillomavirus type 52 expressed in Escherichia coli BL21 (DE3)

Recombinant Expression of Truncated Human Papillomavirus 58 L1 Protein with Molecular Chaperones in E.coli